Sponge-Derived Innovation for Dermatology
Sponge-Derived Innovation for Dermatology
with a mission
with a mission
Sponges produce powerful bioactive compounds that one day might treat and prevent many currently incurable diseases.
Sponges produce powerful bioactive compounds that one day might treat and prevent many currently incurable diseases.
An investigational once-weekly topical drug candidate for moderate-to-severe acne. In STAR-1, a 520-patient Phase 3 trial, DMT310 met all three co-primary endpoints.
Villani’s sponge grows in a remote reserve protected by UNESCO and regrows every year, allowing a sustainable annual harvest.
VSM™ Powder is a proprietary cosmetic ingredient used in the Villani Treatment™, an in-office resurfacing and rejuvenation procedure performed by medical professionals.
Villani, Inc. is pursuing partnerships for the development and licensing of DMT310 and DMT410, and collaborations with dermatology practice networks to offer VSM™.